L. Marie Asad is a patient advocate, community engagement leader and currently services as President of the Friends of the PBC Foundation, NFP., an a transformative organization dedicated to serving those affected by Primary Biliary Cholangitis (PBC), in the United States. Ms. Asad, holds a Master of Arts degree in Gerontology from Concordia University, a Leadership Certificate from the Organizational Leadership Institute and Bachelor of Art degree from Illinois State University.
Esther Caparrós holds a PhD in Biological Sciences and is a Professor of Immunology at Miguel Hernández University in Alicante. She is a member of the Hepatic and Intestinal Immunobiology Group, where she studies the interaction between the immune response and the translocation of bacterial products in chronic inflammatory liver and intestinal diseases. She investigates the molecular and cellular aspects of the immune system responsible for surveillance, response, and regulation of homeostasis in the liver-intestine axis.
Jim is a Professor at MSU and his research program focuses on blood coagulation and liver disease
Dr. Monga is the SVC Endowed Chair in Pathobiology and Therapeutics and Professor of Pharmacology and Medicine at the University of Pittsburgh. He is the Chair/Director of the Organ Pathobiology and Therapeutics Institute. He is also the director of the Pittsburgh Liver Research Center, an NIDDK P30 funded Digestive Disease Research Core Center and the program director of the Cellular Approaches to Tissue Engineering and Regeneration, NIBIB T32 funded predoctoral training program. He serves as the Associate Dean of Research for the University of Pittsburgh School of Medicine.
I happily wear the label of physician-scientist and am on the faculty of Keck Medicine of the University of Southern California. Rather than describing myself, I would rather tell you about some of our research. Since my Fellowship, my basic science has focused on the liver sinusoidal endothelial cell, the LSEC.
Dr. Hilscher is a Transplant Hepatologist and physician-scientist at the Mayo Clinic in Rochester, MN. She has NIH funding with a K08 Career Development Award with which she investigates the mechanisms of portal hypertension. She has a particular research and clinical interest in vascular diseases of the liver including Fontan associated liver disease.
Dr. Valerie Gouon-Evans is Professor of Medicine, Gastroenterology Section, Center for Regenerative Medicine, Boston University School of Medicine, Boston Medical Center.
I am a molecular and vascular biologist specialized in the liver heterogeneity, I have a broad background in biology and bioinformatic analysis that allow me studing the molecular mechanisms controlling the vascular fate and its influence on organ homeostasis. My research focuses on understanding the molecular mechanisms regulating endothelial cell signature and adaptability to expand the "Vascular Medicine" field. The ovearching goal of my laboratory is to develop novel strategies to heal the liver throught recovering the regenerative function of its blood vessels.
Jordi Gracia-Sancho MSc PhD FAASLD is the Chief of the Liver Vascular Biology Research Group at the IDIBAPS Research Institute – Hospital Clínic de Barcelona, Associate Researcher at the Department of Visceral Surgery and Medicine – University of Bern, & Scientific Director of the Spanish Research Consortium on Liver & Digestive Diseases (CIBEREHD), National Institute of Health, Spanish Ministry of Science, Innovation and Universities.<br><br>Jordi's research focuses on liver vascular pathobiology with special interest in the role of sinusoidal cells, and their inte
Dr. Shah serves as the Mr. and Mrs. Ronald F. Kinney Executive Dean of Research Honoring Ronald F. Kinney, Jr. and the Carol M. Gatton Professor of Digestive Diseases Research, Honoring Peter Carryer, M.D. at Mayo Clinic in Rochester. He has been on staff at Mayo Clinic for 25 years and previously served as Chairs of the Division of Gastroenterology and Hepatology and Department of Medicine. Dr.